Molecular Diagnostics
Spinal Fluid Biomarkers Predict Cognitive Decline in Individuals with Familial Risk of Alzheimer's Disease
Determination of two biomarkers in cerebrospinal fluid allows prediction of development of cognitive impairment up to five years before appearance of symptoms in normal patients with familial risk of Alzheimer's disease. More...31 Oct 2013
In Other News
Qiagen and Clovis Oncology Jointly to Develop Companion Diagnostic
Genetic Disease Causes Recurrent Respiratory Infections
Potential Molecular Biomarker Identified for Sepsis
New Survey Reveals Large Number of Prion Carriers in the United Kingdom
Hereditary Cancer Assay Improves Colon Cancer Testing
Protein Identified That May Predict Thyroid Cancer Recurrence
Six Additional Sjögren's Syndrome Genes Identified
Diagnostic Test Clinically Validated for Breast Cancer Mutations
Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett's Esophagus
DNA Extraction Kits Enable Molecular Confirmation of Genetic Disorders
Identified Genes Associated with Unhealthy Liver Function
Method Determines Whether an Unborn Baby Has Down's Disease
Biomarkers Help Predict Outcome in Deadly Lung Disease
People Identified at High-Risk of Developing Rheumatoid Arthritis
Fragile X Syndrome Protein Linked to Breast Cancer
Biomarker Identified for Smoker’s Lung Cancer
Gene-Expression Biomarker Predicts Risk of Breast Cancer Recurrence
Molecular Basis of Alzheimer’s Disease Determined
Molecular Test Identifies Indolent Prostate Cancer
Genetic Cause of Childhood Leukemia Identified
Genetic Deletion Linked to Early-Onset Parkinson's Disease
Molecular Method Detects Colon Cancer Earlier
Methods Evaluated for HER2 Status in Breast Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.